Characterization of five novel vasopressin V2 receptor mutants causing nephrogenic diabetes insipidus reveals a role of tolvaptan for M272R-V2R mutation
出版年份 2020 全文链接
标题
Characterization of five novel vasopressin V2 receptor mutants causing nephrogenic diabetes insipidus reveals a role of tolvaptan for M272R-V2R mutation
作者
关键词
-
出版物
Scientific Reports
Volume 10, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-10-02
DOI
10.1038/s41598-020-73089-x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Diabetes insipidus
- (2019) Mirjam Christ-Crain et al. Nature Reviews Disease Primers
- Evaluation of pharmacochaperone-mediated rescue of mutant V2 receptor proteins
- (2019) Beril Erdem Tuncdemir et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- A mouse model of pseudohypoaldosteronism type II reveals a novel mechanism of renal tubular acidosis
- (2018) Karen I. López-Cayuqueo et al. KIDNEY INTERNATIONAL
- Integrin Beta 1 Is Crucial for Urinary Concentrating Ability and Renal Medulla Architecture in Adult Mice
- (2018) Anna Iervolino et al. Frontiers in Physiology
- GPCRdb in 2018: adding GPCR structure models and ligands
- (2017) Gáspár Pándy-Szekeres et al. NUCLEIC ACIDS RESEARCH
- Systems-level identification of PKA-dependent signaling in epithelial cells
- (2017) Kiyoshi Isobe et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Evolutionary action and structural basis of the allosteric switch controlling β2AR functional selectivity
- (2017) Anne-Marie Schönegge et al. Nature Communications
- Pharmacological Chaperones: Design and Development of New Therapeutic Strategies for the Treatment of Conformational Diseases
- (2016) Marino Convertino et al. ACS Chemical Biology
- Genetic forms of nephrogenic diabetes insipidus (NDI): Vasopressin receptor defect (X-linked) and aquaporin defect (autosomal recessive and dominant)
- (2016) Daniel G. Bichet et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Analysis of the V2 Vasopressin Receptor (V2R) Mutations Causing Partial Nephrogenic Diabetes Insipidus Highlights a Sustainable Signaling by a Non-peptide V2R Agonist
- (2016) Noriko Makita et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Treatment of Fabry’s Disease with the Pharmacologic Chaperone Migalastat
- (2016) Dominique P. Germain et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sildenafil for the Treatment of Congenital Nephrogenic Diabetes Insipidus
- (2015) Farahnak Assadi et al. AMERICAN JOURNAL OF NEPHROLOGY
- Ibuprofen rescues mutant cystic fibrosis transmembrane conductance regulator trafficking
- (2015) Graeme W. Carlile et al. Journal of Cystic Fibrosis
- Selective Dicer Suppression in the Kidney Alters GSK3β/β-Catenin Pathways Promoting a Glomerulocystic Disease
- (2015) Anna Iervolino et al. PLoS One
- A randomized controlled pilot trial of lithium in spinocerebellar ataxia type 2
- (2014) Francesco Saccà et al. JOURNAL OF NEUROLOGY
- The role of the kidney in salt-sensitive hypertension
- (2011) Francesco Trepiccione et al. Clinical and Experimental Nephrology
- V2 Vasopressin Receptor (V2R) Mutations in Partial Nephrogenic Diabetes Insipidus Highlight Protean Agonism of V2R Antagonists
- (2011) Kazuhiro Takahashi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809
- (2011) F. Van Goor et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Preclinical Evidence that Sildenafil and Vardenafil Activate Chloride Transport in Cystic Fibrosis
- (2007) Bob Lubamba et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started